1st Annual International Symposium of Fusobacteria
Thursday, April 15, 2021
9:00 a.m. - 5:45 p.m. (NYC/Eastern Standard Time)
The registration period has closed for this event.
Hosted by
Columbia University College of Dental Medicine
with the
Columbia University Herbert Irving Comprehensive Cancer Center
and
Anaerobe Society of the Americas
Supported in part by Virtual Exhibitor:
Anaerobe, published by ELSEVIER
Pre-registration is required to access the Symposium.
Zoom details will be forwarded prior to the event.
If you'd like help registering, we are happy to assist.
Email dentalce@columbia.edu or call +1212/305-7124 with your details.
NOTE: Do not provide credit card information via email - we will follow-up separately.
$100 - Non-academic
$25 - Academic
$5 - Resident/Postdoc/Student
Complimentary -
Columbia University & CUIMC- Faculty/Staff/Resident/Postdoc/Student
Virtual lectures, via Zoom, with live presentations and Q&A opportunities.
Hosted virtually by Columbia University College of Dental Medicine and the Herbert Irving Comprehensive Cancer Center, located at Columbia University Irving Medical Center, Washington Heights, New York City.
As a result of COVID-19, our in-person courses are currently on pause for the safety and well-being of the Columbia community and campus visitors. We look forward to welcoming guests back to campus once it is safe to do so. Meanwhile we look forward to your participation in our LIVE VIRTUAL sessions, with interactive Q&A and chat opportunities.
Conference Chair
Dr. Yiping Han, Columbia University, USA
Scientific Committee
Dr. Yiping Han, Columbia University, USA
Dr. Gilad Bachrach, Hebrew University, Israel
Dr. Jorg Vogel, University of Wurzburg, Germany
CLICK HERE FOR DOWNLOADABLE PDF: Click here to open 2021_0415_FusobacteriaSymposium_Flyer_FINAL.pdf
AGENDA
9:00-9:05 a.m. - Opening Remarks
9:05-10:00 a.m. - Keynote - Convener: Adam Bass
Matthew Meyerson, Dana-Farber Cancer Institute
“Fusobacterium Association with Colon Cancer: What could it mean?”
10:05-11:35 a.m. - Cancer Session I - Convener: Yiping Han
10:05-10:35 a.m. - Jie Hong, Shanghai Jiaotong University
“Fusobacterium Nucleatum Targets lncRNA ENO1-IT1 to Promote Glycolysis and Oncogenesis in Colorectal Cancer”
10:35-11:05 a.m. - Hideo Baba, Kumamoto University
“Fusobacterium Nucleatum and Esophageal Cancer”
11:05-11:35 a,m. - Gilad Bachrach, Hebrew University
“Tumor Targeting by Fusobacterium Nucleatum”
11:35-12:05 Break
12:05-1:35 Cancer Session II - Convener: Jorg Vogel
12:05-12:35 a.m. - Shuji Ogino, Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health
Integrative Analyses of Lifestyle, Microbiota, and Tumor Immunity Give Insight into Etiologies
12:35-1:05 a.m. - Robert Holt, University of British Columbia
F. nucleatum and Host Immunity
1:05-1:35 a.m. - Wendy Garrett, Harvard University
Aspirin and Fusobacterium nucleatum
1:35-2:05 p.m.- Break
2:05-3:35 pm. Virulence Factors Session I - Convener: Gilad Bachrach
2:05-2:35 a.m. - Jorg Vogel, Helmholtz Institute for RNA-based Infection Research
“The RNA Road to Understanding Fusobacterium Nucleatum”
2:35-3:05 a.m. - Emma Allen-Vercoe, University of Guelph
“Predation of Fusobacterium Nucleatum by Bdellovibrio spp: potential for therapeutic exploitation”
3:05-3:35 a.m. - Yiping Han, Columbia University
“Novel Insights into the Virulence Properties of FadA”
3:35-4:05 Break
4:05-5:35 Virulence Factors Session II - Convener: Yiping Han
4:05-4:35 a.m. - Hung Ton-That, UCLA
“Experimental Approaches to Define Virulent Determinants in Fusobacterium Nucleatum“
4:35-5:05 a.m. - Daniel Slade, Virginia Tech
“Taming the Beast: Bypassing RM Systems in Fusobacterium“
5:05-5:35 a.m. - Renate Lux, UCLA
“The rad operon of Fusobacterium nucleatum“
5:35-5:45 Closing Remarks
Adam Bass, MD - Columbia University - Precision Cancer Center
Keynote: Matthew Meyerson, MD, PhD - Dana-Farber Cancer Institute
Dr. Meyerson serves as Professor of Pathology at Dana-Farber Cancer Institute and Harvard Medical School, as Director of the Center for Cancer Genome Discovery at DFCI (with Dr. William Hahn), and as Senior Associate Member of the Broad Institute. Dr. Meyerson received his MD in 1993 and PhD in 1994 from Harvard University. After a residency in clinical pathology at Massachusetts General Hospital and a research fellowship with Dr. Robert Weinberg at the Whitehead Institute, he joined DFCI in 1998. Dr. Meyerson has concentrated on using genomic approaches to understand the biology and genetics of human lung carcinomas. More broadly, his laboratory is focused on cancer genome discovery and pathogen discovery in human disease.
Emma Allen-Vercoe, PhD - University of Guelph, Ontario Canada
Hideo Baba, MD, PhD - Kumamoto University, Japan
Gilad Bachrach, PhD - Hebrew University-Hadassan School of Dental Medicine, Israel
Wendy Garrett, MD, PhD - Harvard University, MA, USA
Yiping Han, PhD - Columbia University, NY, USA
Robert Holt, PhD - University of British Columbia, Canada
Jie Hong, PhD - Shanghai Jiao Tong University School of Medicine, PRC
Renate Lux, PhD - UCLA School of Dentistry, CA, USA
Shuji Ogino, MD, PhD -Brigham and Women's Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, MA, USA
Daniel Slade, PhD - Virginia Tech University, VA, USA
Hung Ton-That, PhD - UCLA School of Dentistry, CA, USA
Jorg Vogel, PhD - University of Wurzburg, Germany - NEWS Jan.'21
For THOSE WHO REQUIRE CDE CREDITS:
Columbia University CDM designates this lecture course for Continuing Dental Education: Credits - 7
Columbia University College of Dental Medicine is an ADA CERP Recognized Provider 11/1/17 through 6/30/22. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Participants: Continuing Education credits awarded for participation in the CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of his/her licensing board(s) and to report credits to the appropriate authority.
Columbia University College of Dental Medicine is located in the Columbia University Irving Medical Center in Washington Heights, New York City.
Columbia University College of Dental Medicine
630 West 168th Street (Box 20)
(located bet. Broadway and Ft. Washington Ave.)
New York, NY 10032
https://www.dental.columbia.edu/about-us
Columbia University College of Dental Medicine
Visit Columbia's Coronavirus Resource Center